For the Inventor, By the Inventor

Enter assignee name

Santa Clara, CA, United States of America

Cardiva Medical, Inc.

Calculating rank

USPTO Granted Patents = 29

% Expired Patents = 3.4

EPO Patents = 5

Forward Citations = 354

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Zia Yassinzadeh (29 out of 34 patents)

Delfin Pelayo (5 out of 5 patents)

Jeffrey I Weitz (4 out of 14 patents)

4. Alan Stafford (4 out of 5 patents)

5. Justin L Ballotta (4 out of 4 patents)

6. John L Russell (4 out of 4 patents)

7. Todd E Lempert (1 out of 9 patents)

8. Richard M Romley (1 out of 6 patents)

9. Glenn Foy (1 out of 8 patents)

10. David Mark Taylor (1 out of 110 patents)

11. Brian Benjamin Martin (1 out of 84 patents)

12. Gordon Howard Epstein (1 out of 38 patents)

Core Competencies:

Hemostasis

Vascular Closure

Catheter

Occlusion

Blood Vessel

Drug Eluting

Self-Tensioning

Sealing Device

29 patents: Sort by Forward Citations

1. 12514574 - Catheter with sealed hydratable hemostatic occlusion element (2026-01-06),

2. 12349885 - Apparatus and methods for accessing and closing multiple penetrations on a blood vessel (2025-07-08),

3. 11871916 - Vascular closure devices and methods providing hemostatic enhancement (2024-01-16),

4. 11723640 - Apparatus and methods for accessing and closing multiple penetrations on a blood vessel (2023-08-15),

5. 11717278 - Apparatus and methods for delivering hemostatic materials for blood vessel closure (2023-08-08),

6. 11690608 - Catheter with sealed hydratable hemostatic occlusion element (2023-07-04),

7. 10779808 - Catheter with sealed hydratable hemostatic occlusion element (2020-09-22),

8. 10660627 - Apparatus and methods for accessing and closing multiple penetrations on a blood vessel (2020-05-26),

9. 10531868 - Apparatus and methods for accessing and closing multiple penetrations on a blood vessel (2020-01-14),

10. 10376255 - Bilateral vessel closure (2019-08-13),

11. 10363021 - Vascular closure devices and methods providing hemostatic enhancement (2019-07-30),

12. 10327747 - Apparatus and methods for delivering hemostatic materials for blood vessel closure (2019-06-25),

13. 10130347 - Hemostasis-enhancing device and method for its use (2018-11-20),

14. 9597066 - Vascular closure devices and methods providing hemostatic enhancement (2017-03-21),

15. 9439637 - Apparatus and methods for delivering hemostatic materials for blood vessel closure (2016-09-13),

Company Overview

Cardiva Medical, Inc. is a medical device company based in Santa Clara, California, specializing in innovative solutions for vascular closure. The company focuses on developing advanced technologies that enhance patient safety and improve clinical outcomes in minimally invasive procedures. Cardiva's expertise lies in creating devices that facilitate rapid and effective closure of vascular access sites, addressing the needs of healthcare providers and patients in various medical settings. Their commitment to innovation positions them as a key player in the evolving landscape of medical technology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

29 Patents

#122 in Santa Clara, CA

#2,768 in California

#11,631 in US

#22,563 in the World

Santa Clara, CA, United States of America

Cardiva Medical, Inc.

Forward Citations = 354

12 inventors:

Zia Yassinzadeh (29 out of 34 patents)

Delfin Pelayo (5 out of 5 patents)

Jeffrey I Weitz (4 out of 14 patents)

4. Alan Stafford (4 out of 5 patents)

5. Justin L Ballotta (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cardiva Medical, Inc.. Retrieved from https://idiyas.com/company/cardiva-medical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…